Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Gluconate for Recurrent Vulvovaginal Candidiasis
NCT05059145Phase 2Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Apr 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorhexidine in vulvovaginal candidiasis (VVC), sponsored by Karolinska Institutet. Started Apr 2022; status: recruiting.
02
Drugs
chlorhexidine
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT05059145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059145.